Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 10 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000776 | kinetochore | 3 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0099080 | supramolecular complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AND5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 16 | 20 | PF00656 | 0.534 |
CLV_C14_Caspase3-7 | 68 | 72 | PF00656 | 0.559 |
CLV_MEL_PAP_1 | 138 | 144 | PF00089 | 0.497 |
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.425 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.412 |
CLV_PCSK_KEX2_1 | 243 | 245 | PF00082 | 0.584 |
CLV_PCSK_PC1ET2_1 | 243 | 245 | PF00082 | 0.584 |
DOC_CYCLIN_yCln2_LP_2 | 149 | 155 | PF00134 | 0.361 |
DOC_CYCLIN_yCln2_LP_2 | 31 | 37 | PF00134 | 0.476 |
DOC_MAPK_gen_1 | 4 | 13 | PF00069 | 0.466 |
DOC_MAPK_MEF2A_6 | 151 | 159 | PF00069 | 0.535 |
DOC_MIT_MIM_1 | 137 | 145 | PF04212 | 0.534 |
DOC_PP2B_LxvP_1 | 31 | 34 | PF13499 | 0.538 |
DOC_USP7_MATH_1 | 214 | 218 | PF00917 | 0.582 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.538 |
DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.473 |
LIG_14-3-3_CanoR_1 | 132 | 142 | PF00244 | 0.484 |
LIG_Actin_WH2_2 | 59 | 77 | PF00022 | 0.506 |
LIG_BRCT_BRCA1_1 | 138 | 142 | PF00533 | 0.527 |
LIG_BRCT_BRCA1_1 | 63 | 67 | PF00533 | 0.512 |
LIG_FHA_1 | 159 | 165 | PF00498 | 0.552 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.560 |
LIG_FHA_1 | 227 | 233 | PF00498 | 0.375 |
LIG_FHA_2 | 119 | 125 | PF00498 | 0.476 |
LIG_FHA_2 | 204 | 210 | PF00498 | 0.487 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.462 |
LIG_LIR_Gen_1 | 139 | 150 | PF02991 | 0.536 |
LIG_LIR_Gen_1 | 170 | 179 | PF02991 | 0.451 |
LIG_LIR_Gen_1 | 190 | 198 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.458 |
LIG_LIR_Nem_3 | 139 | 145 | PF02991 | 0.536 |
LIG_LIR_Nem_3 | 170 | 175 | PF02991 | 0.423 |
LIG_LIR_Nem_3 | 190 | 195 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 56 | 61 | PF02991 | 0.425 |
LIG_NRBOX | 230 | 236 | PF00104 | 0.447 |
LIG_SH2_CRK | 192 | 196 | PF00017 | 0.431 |
LIG_SH2_STAP1 | 192 | 196 | PF00017 | 0.470 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.389 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.519 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.500 |
LIG_SH3_3 | 160 | 166 | PF00018 | 0.476 |
LIG_SUMO_SIM_par_1 | 9 | 14 | PF11976 | 0.451 |
LIG_UBA3_1 | 231 | 238 | PF00899 | 0.447 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.578 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.620 |
MOD_CK1_1 | 226 | 232 | PF00069 | 0.456 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.510 |
MOD_CK2_1 | 203 | 209 | PF00069 | 0.521 |
MOD_CK2_1 | 213 | 219 | PF00069 | 0.531 |
MOD_CK2_1 | 221 | 227 | PF00069 | 0.477 |
MOD_CK2_1 | 234 | 240 | PF00069 | 0.405 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.430 |
MOD_GSK3_1 | 132 | 139 | PF00069 | 0.551 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.504 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.400 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.316 |
MOD_N-GLC_1 | 99 | 104 | PF02516 | 0.493 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.545 |
MOD_NEK2_1 | 234 | 239 | PF00069 | 0.482 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.450 |
MOD_PIKK_1 | 190 | 196 | PF00454 | 0.450 |
MOD_PIKK_1 | 66 | 72 | PF00454 | 0.554 |
MOD_PIKK_1 | 88 | 94 | PF00454 | 0.472 |
MOD_PK_1 | 123 | 129 | PF00069 | 0.580 |
MOD_PKA_1 | 140 | 146 | PF00069 | 0.500 |
MOD_PKA_2 | 131 | 137 | PF00069 | 0.535 |
MOD_PKA_2 | 140 | 146 | PF00069 | 0.467 |
MOD_PKA_2 | 74 | 80 | PF00069 | 0.475 |
MOD_Plk_4 | 61 | 67 | PF00069 | 0.407 |
MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.469 |
MOD_SUMO_rev_2 | 124 | 131 | PF00179 | 0.579 |
TRG_DiLeu_BaEn_1 | 227 | 232 | PF01217 | 0.525 |
TRG_DiLeu_BaLyEn_6 | 230 | 235 | PF01217 | 0.487 |
TRG_ENDOCYTIC_2 | 192 | 195 | PF00928 | 0.468 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.507 |
TRG_ENDOCYTIC_2 | 6 | 9 | PF00928 | 0.348 |
TRG_ER_diArg_1 | 140 | 142 | PF00400 | 0.436 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5W4 | Leptomonas seymouri | 55% | 100% |
A0A0S4JKW0 | Bodo saltans | 28% | 70% |
A0A1X0NQF7 | Trypanosomatidae | 29% | 100% |
A0A3S7WRE7 | Leishmania donovani | 95% | 100% |
A0A422NBU0 | Trypanosoma rangeli | 34% | 100% |
A4H6B3 | Leishmania braziliensis | 80% | 100% |
A4HUN6 | Leishmania infantum | 95% | 100% |
C9ZVS5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 93% |
E9ACR0 | Leishmania major | 95% | 100% |
V5BPA9 | Trypanosoma cruzi | 30% | 100% |